GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Cyclically Adjusted FCF per Share

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Cyclically Adjusted FCF per Share : $-0.38 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medexus Pharmaceuticals's adjusted free cash flow per share for the three months ended in Dec. 2023 was $0.229. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.38 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-05-17), Medexus Pharmaceuticals's current stock price is $1.21. Medexus Pharmaceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $-0.38. Medexus Pharmaceuticals's Cyclically Adjusted Price-to-FCF of today is .


Medexus Pharmaceuticals Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Medexus Pharmaceuticals's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Cyclically Adjusted FCF per Share Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.55 -0.50

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.50 -0.48 -0.43 -0.38

Competitive Comparison of Medexus Pharmaceuticals's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medexus Pharmaceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's Cyclically Adjusted Price-to-FCF falls into.



Medexus Pharmaceuticals Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medexus Pharmaceuticals's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.229/125.0724*125.0724
=0.229

Current CPI (Dec. 2023) = 125.0724.

Medexus Pharmaceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 -0.694 96.945 -0.895
201406 -0.341 99.473 -0.429
201409 -0.174 99.394 -0.219
201412 -0.300 98.367 -0.381
201503 -0.120 99.789 -0.150
201506 -0.225 100.500 -0.280
201509 -0.218 100.421 -0.272
201512 -0.117 99.947 -0.146
201603 0.217 101.054 0.269
201606 0.249 102.002 0.305
201609 -0.218 101.765 -0.268
201612 -0.153 101.449 -0.189
201703 -0.136 102.634 -0.166
201706 -0.347 103.029 -0.421
201709 -0.118 103.345 -0.143
201712 -0.046 103.345 -0.056
201803 -0.124 105.004 -0.148
201806 -0.045 105.557 -0.053
201809 -0.049 105.636 -0.058
201812 -0.109 105.399 -0.129
201903 0.049 106.979 0.057
201906 -0.048 107.690 -0.056
201909 0.013 107.611 0.015
201912 -0.057 107.769 -0.066
202003 -0.093 107.927 -0.108
202006 0.206 108.401 0.238
202009 -0.002 108.164 -0.002
202012 -0.195 108.559 -0.225
202103 -0.335 110.298 -0.380
202106 -0.656 111.720 -0.734
202109 0.181 112.905 0.201
202112 -0.100 113.774 -0.110
202203 0.108 117.646 0.115
202206 -0.202 120.806 -0.209
202209 0.038 120.648 0.039
202212 -0.111 120.964 -0.115
202303 0.167 122.702 0.170
202306 0.207 124.203 0.208
202309 0.359 125.230 0.359
202312 0.229 125.072 0.229

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Medexus Pharmaceuticals  (OTCPK:MEDXF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medexus Pharmaceuticals Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medexus Pharmaceuticals (Medexus Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Headlines

From GuruFocus

Treosulfan NDA Resubmitted to FDA

By PurpleRose PurpleRose 07-25-2022

Medexus Schedules Second Quarter 2023 Conference Call

By Value_Insider Value_Insider 11-02-2022

Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call

By GuruFocusNews GuruFocusNews 06-24-2022

Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update

By Stock market mentor Stock market mentor 01-12-2023

Treosulfan Pivotal Study Results Published

By GuruFocusNews GuruFocusNews 06-16-2022

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

By Stock market mentor Stock market mentor 01-31-2023